Stocks and Investing Stocks and Investing
Thu, March 11, 2021
Wed, March 10, 2021

Tazeen Ahmad Downgraded (ACAD) to Hold on, Mar 10th, 2021


Published on 2024-10-27 15:54:43 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold on, Mar 10th, 2021.

Tazeen has made no other calls on ACAD in the last 4 months.



There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 3 agree with Tazeen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $27 on, Tuesday, March 9th, 2021
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Tuesday, March 9th, 2021


These are the ratings of the 6 analyists that currently disagree with Tazeen


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $43 on, Tuesday, March 9th, 2021
  • Danielle Brill of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Tuesday, March 9th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $44 on, Tuesday, March 9th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, March 9th, 2021
  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
Contributing Sources